Ohnishi Kazunori | The Division Of Hematology Department Of Medicine Iii Hamamatsu University School Of Medicine
スポンサーリンク
概要
- 同名の論文著者
- The Division Of Hematology Department Of Medicine Iii Hamamatsu University School Of Medicineの論文著者
関連著者
-
OHASHI Kazuteru
Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
AKIYAMA Hideki
Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
SAKAMAKI Hisashi
Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
三木 義男
癌研ゲノムセンター
-
Morishima Y
Department Of Hematology Kinki University School Of Medicine
-
Miyazaki Yoshitsugu
長崎大学 第二内科
-
Moriwaki Yuji
長崎大学大学院医歯薬学総合研究科附属原爆後障害医療研究施設 分子治療研究分野
-
NAOE Tomoki
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
Tobinai K
Hematology And Stem Cell Transplantation Divisions National Cancer Center Hospital
-
Kishimoto Yuji
The First Department Of Internal Medicine Kansai Medical University
-
Tsuboi Naoya
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Kagami Y
Department Of Hematology Japanese Red Cross Nagoya First Hospital
-
Tsuboi Naoya
Cardiovascular Center Nagoya Daini Red Cross Hospital
-
Tsuboi Naoya
Division Of Cardiology Nagoya Daini Red Cross Hospital
-
Maeda S
Center For Hematopoietic Disorders Ohta Nishinouchi Hospital The Ohta Foundation
-
Seto M
Department Of Hematology And Chemotherapy
-
Seto Masao
愛知県がんセンター研究所 分子腫瘍学部
-
Seto Masao
東京大学医学部附属病院 無菌治療部
-
Osaki Koichi
九州厚生年金病院
-
OHNO Ryuzo
Aichi Cancer Center
-
OHSHIMA Koichi
Department of Pathology, Kurume University School of Medicine
-
Nakamura S
Department Of Pathology Nagoya University School Of Medicine
-
Nakamura Shigeo
国立がんセンター中央病院 血液内科
-
Nakamura Shigeo
群馬県立がんセンター 病理検査
-
Kato T
Department Of Gastroenterological Surgery Aichi Cancer Center Hospital
-
Nakagawa Shun-ichi
鈴鹿中央総合病院(厚生連)
-
Naoe Tomoki
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
YOSHINO Tadashi
Department of Pathology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutica
-
MIYAZAKI Yasushi
Department of Hematology, Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Universit
-
YAGASAKI Fumiharu
Department of Hematology, Saitama Medical University Hospital
-
MORIUCHI Yukiyoshi
Department of Hematology, Sasebo City General Hospital
-
坂本 弘明
Department of Internal Medicine II, Fukushima Medical University, School of Medicine
-
Katayama Y
Division Of Hematology Saitama Medical Center Jichi Medical University
-
NAKAMURA Shigeo
Department of Clinical Pathology, Aichi Cancer Center Hospital
-
SUGIYAMA Haruo
Departments of Clinical Laboratory Science
-
CHOU Takaaki
Department of Internal Medicine, Niigata Cancer Center Hospital
-
OHNISHI Kazunori
Department of Internal Medicine, Hamamatsu University School of Medicine
-
SHIMOYAMA Masanori
National Cancer Center Hospital
-
斉藤 広信
福島県立医科大学 医学部内科学第二講座
-
Shimoda Kazuya
九州大学 医学部病態情報学
-
Komatsu H
Department Of Medical Oncology And Immunology Nagoya City University Graduate School Of Medical Scie
-
Shimoda Kazuya
九州大学 第1内科
-
Akashi Koichi
九州大学 医学研究院病態修復内科学
-
Akashi Koichi
Medicine And Biosystemic Science Kyushu University Graduate School Of Medical Sciences
-
MIYAWAKI Shuichi
Division of Hematology, Saiseikai Maebashi Hospital
-
KIYOI Hitoshi
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
OKUMURA Hirokazu
Department of Hematology, Kanazawa University Graduate School of Medical Science
-
NAGAI Tadashi
Division of Hematology, Jichi Medical University
-
TAKEUCHI Jin
Department of Hematology and Rheumatology, Nihon University School of Medicine
-
ASOU Norio
Department of Hematology, Kumamoto University School of Medicine
-
SEKI Ritsuko
Division of Hematology and Oncology, Department of Medicine, Kurume University School of Medicine
-
FUJISAKI Tomoaki
Department of Internal Medicine, Matsuyama Red Cross Hospital
-
UIKE Naokuni
Department of Hematology, National Kyushu Cancer Center
-
KAWANO Fumio
Department of Internal Medicine, National Hospital Organization, Kumamoto Medical Center
-
GONDO Hisashi
Department of Internal Medicine, Saga Prefectural Hospital Koseikan
-
MAKINO Shigeyoshi
Department of Internal Medicine, Miyazaki Prefectural Hospital
-
ETO Tetsuya
Department of Hematology, Hamanomachi Hospital
-
TAGUCHI Fumihiro
Department of Hematology, Iizuka Hospital
-
KAMIMURA Tomohiko
Department of Hematology, Harasanshin General Hospital
-
TSUDA Hiroyuki
Division of Clinical Hematology, Kumamoto City Hospital
-
OGAWA Ryosuke
Shimonoseki City Central Hospital
-
SHIMODA Kazuya
Department of Internal Medicine, Gastroenterology and Hematology, Faculty of Medicine, Miyazaki Univ
-
YAMASHITA Kiyoshi
Department of Internal Medicine, Gastroenterology and Hematology, Faculty of Medicine, Miyazaki Univ
-
SUZUKI Keiko
Department of Internal Medicine, Koga General Hospital
-
SUZUSHIMA Hitoshi
Department of Internal Medicine, NTT Nishinippon Kyushu General Hospital
-
TSUKAZAKI Kunihiro
Molecular Medicine Unit and Hematology, Atomic Bomb Disease Institute, Nagasaki University Graduate
-
HIGUCHI Masakazu
Department of Internal Medicine, Kyushu Kosei-nenkin Hospital
-
UTSUNOMIYA Atae
Department of Hematology, Imamura Bun-in Hospital
-
IWAHASHI Masahiro
Department of Internal Medicine, Saiseikai-Hita Hospital
-
IMAMURA Yutaka
Department of Hematology, St. Mary Hospital
-
TAMURA Kazuo
Division of Medical Oncology and Hematology, Department of Medicine, Fukuoka University Hospital
-
SUZUMIYA Junji
Department of Internal Medicine, Fukuoka University Chikushi Hospital
-
YOSHIDA Minoru
Japanese Red Cross Kumamoto Health Care Center
-
ABE Yasunobu
Department of Medicine and Bioregulatory Science, Graduate School of Medical Science, Kyushu Univers
-
MATSUMOTO Tadashi
Department of Hematology, Imamura Hon-in Hospital
-
OKAMURA Takashi
Division of Hematology, Department of Medicine, Kurume University School of Medicine
-
永井 正
自治医科大学内科学講座血液学部門
-
MORI Shinichiro
Hematopoietic Stem Cell Transplantation Unit, National Cancer Center Hospital
-
TOBINAI Kensei
Hematology and Stem Cell Transplantation Divisions, National Cancer Center Hospital
-
OGURA Michinori
Department of Hematology and Cell Therapy, Aichi Cancer Center
-
MORISHIMA Yasuo
Department of Hematology and Cell Therapy, Aichi Cancer Center
-
KAGAMI Yoshitoyo
Department of Hematology and Cell Therapy, Aichi Cancer Center
-
ITOH Kuniaki
Division of Oncology and Hematology, National Cancer Center Hospital East
-
Tobinai Kensei
国立がんセンター中央病院 血液内科グループ
-
KINOSHITA Tomohiro
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
Miyamoto Toshihiro
Medicine And Biosystemic Science Kyushu University Graduate School Of Medical Sciences
-
Minami H
Medical Oncology Department Of Medicine Kobe University Hospital And Graduate School Of Medicine
-
Minami Hironobu
神戸大学 医学研究科腫瘍内科学
-
SUZUKI Ritsuro
Department of HSCT Data Management, Nagoya University Hospital
-
永井 正
自治医科大学 内科学講座血液学部門
-
岡田 昌也
兵庫医科大学総合内科学血液・腫瘍科
-
TAWARA Masayuki
Nagasaki CML Study Group
-
Okamura T
Division Of Hematology Department Of Medicine Kurume University School Of Medicine
-
Hashiguchi Michitoshi
Division Of Hematology Department Of Medicine Kurume University School Of Medicine
-
Seki Ritsuko
Division Of Hematology And Oncology Department Of Medicine Kurume University School Of Medicine
-
Seki Ritsuko
久留米大学 医学部血液内科
-
Seki Ritsuko
Second Dep. Of Internal Medicine Kurume Univ. School Of Medicine
-
Seki Ritsuko
司測研
-
Yoshimoto Koji
Division Of Hematology Department Of Medicine Kurume University School Of Medicine
-
Tsuda Hiroyuki
Division Of Clinical Hematology Kumamoto City Hospital
-
Shimoda K
Department Of Internal Medicine Gastroenterology And Hematology Faculty Of Medicine Miyazaki Univers
-
MEGURO KUNIAKI
National Sendai Hospital
-
Miyamoto Toshihiro
九州大学 医学研究院病態修復内科学
-
三木 義男
東京医歯大 難治疾患研 疾患医科学研究系分子遺伝分野
-
Minauchi Koichiro
Second Department Of Medicine Hokkaido University Graduate School Of Medicine
-
Tanaka H
Tanaka Hospital
-
Tanaka Hisato
札幌医科大学 医学部
-
YAMAGUCHI Toshikazu
Development of Clinical Genomics, BML
-
MORITA Yasuyoshi
Department of Hematology, Kinki University School of Medicine
-
KANAMARU Akihisa
Department of Hematology, Kinki University School of Medicine
-
IMANISHI Daisuke
Department of Hematology, Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Universit
-
TANIMOTO Mitsune
Blood Transfusion Division, Department of Internal Medicine II, Okayama University Graduate School o
-
KURIYAMA Kazutaka
Blood Immunology Laboratory, School of Health Sciences, Faculty of Medicine and University Hospital,
-
KOBAYASHI Toru
Department of Hematopoietic Pathobiology and Medical Oncology, Mie University Graduate School of Med
-
IMOTO Shion
Hyogo Prefectural Red Cross Blood Center
-
OHNISHI Kazunori
Third Department of Internal Medicine, Hamamatsu University School of Medicine
-
OHTAKE Shigeki
Department of Hematology, Kanazawa University Graduate School of Medical Science
-
MATSUDA Shin
Center for Hematopoietic Disorders, Ohta Nishinouchi Hospital, The Ohta Foundation
-
KISHIMOTO Yuji
The First Department of Internal Medicine, Kansai Medical University
-
OKADA Masaya
Division of Hematology, Department of Internal Medicine, Hyogo College of Medicine
-
TAKAHASHI Masatomo
Division of Hematology and Oncology, Department of Internal Medicine, St. Marianna University School
-
HANDA Hiroshi
Department of Medicine and Clinical Science, Gunma University Graduate School of Medicine
-
KAGEYAMA Shinichi
Department of Hematology and Oncology, Mie University Graduate School of Medicine
-
MAEDA Yasuhiro
Department of Hematology, Kinki University School of Medicine
-
OHNISHI Kazunori
Oncology Center, Hamamatsu University School of Medicine
-
NAGAFUJI Koji
Division of Hematology and Oncology, Department of Medicine, Kurume University School of Medicine
-
EMI Nobuhiko
Department of Hematology, Fujita Health University
-
Iida Hiroatsu
Department of Hematology, Meitetsu Hospital
-
ISHIKAWA Yuichi
Department of Pathology, the Cancer Institute of JFCR
-
SUGITA Yasuo
Department of Pathology and Biodefense, Saga University, Faculty of Medicine
-
SUZUKI Yoshihiko
Suzuki clinic
-
谷脇 雅文
高知工科大学工学部
-
MIYAMURA Koichi
Department of Hematology, Japanese Red Cross Nagoya First Hospital
-
Yoshida S
Chiba University
-
WATANABE Takashi
Hematology and Stem Cell Transplantation Divisions, National Cancer Center Hospital
-
MATSUNO Yoshihiro
Department of Surgical Pathology, Hokkaido University Hospital
-
HOTTA Tomomitsu
Department of Hematology and Oncology, Tokai University School of Medicine
-
YOSHIDA Shiro
Department of Obstetrics, Center for Perinatal Medicine
-
Kikuchi M
Department Of Pathology School Of Medicine Fukuoka University
-
Tobinai Kensei
東海大学 医学部
-
Yoshida Shiro
Department Of Obstetrics Center For Perinatal Medicine
-
Sadahira Yoshito
Department Of Pathology School Of Medicine Kurume University
-
Saito Y
Division Of Cardiovascular Medicine Kumamoto University Graduate School Of Medical Sciences
-
MIYAZAKI Koji
Departments of Surgery, Saga Medical School
-
Saito Yoshiro
国立医薬品食品衛生研究所
-
TSURUTA Kazuto
the Department of Laboratory Midicine
-
KOHNO Akio
Department of Hematology and Oncology JA Aichi Konan Kosei Hospital
-
NAJIMA Yuho
Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
KAWAMURA Machiko
Pediatrics Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
ONOZUKA Yuji
Development of Clinical Genomics
-
UEDA Yasunori
Department of Pediatrics and Department of Hematology/Oncology, Kurashiki Central Hospital
-
ASANO Naoko
Department of Pathology and Molecular Diagnostics, Aichi Cancer Center
-
ISHIDA Fumihiro
Department of Internal Medicine, Shinshu University School of Medicine
-
OGAWA Hiroshi
Department of Pathology, Seirei Mikatahara General Hospital
-
YOSHIMURA Kenichi
Clinical Trials and Practice Support Division, Center for Cancer Control and Information Services, N
-
OKAMOTO Rumiko
Department of Chemotherapy, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospi
-
HIRANO Masami
Department of Hematology, Fujita Health University School of Medicine
-
ASAOKU Hideki
Clinical Laboratory, Hiroshima Red Cross Hospital, Atomic-Bomb Survivors Hospital
-
KUROSAWA Mitsutoshi
Department of Hematology, National Hospital Organization, Hokkaido Cancer Center
-
MAEDA Yoshiharu
Department of Chemotherapy, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospi
-
OMACHI Ken
Department of Hematology and Oncology, Tokai University School of Medicine
-
KASAI Masaharu
Department of Hematology, Sapporo Hokuyu Hospital
-
TAKAYAMA Nobuyuki
Second Department of Internal Medicine, Kyorin University
-
KABA Harumi
Clinical Trials and Practice Support Division, Center for Cancer Control and Information Services, N
-
YAMAMOTO Seiichiro
Clinical Trials and Practice Support Division, Center for Cancer Control and Information Services, N
-
FUKUDA Haruhiko
Clinical Trials and Practice Support Division, Center for Cancer Control and Information Services, N
-
KIKUCHI Masahiro
Department of Pathology, School of Medicine, Fukuoka University
-
HOTTA Tomomitsu
National Hospital Organization, Nagoya Medical Center
-
HANAMURA Akitoshi
Department of Hematology, Gifu Prefectural Tajimi Hospital
-
KOJIMA Masaru
Department of Anatomic and Diagnostic Pathology, Dokkyo University School of Medicine
-
HIGASHIHARA Masaaki
Department of Hematology, Kitasato University School of Medicine
-
Miura S
Division Of Molecular Medicine Aichi Cancer Center Research Institute
-
USUI Noriko
Department of Medicine, Division of Hematology and Oncology, Jikei University School of Medicine
-
Kojima M
Department Of Anatomic And Diagnostic Pathology Dokkyo University School Of Medicine
-
TANIGUCHI Shuichi
Department of Hematology, Toranomon Hospital
-
Aoki Sadao
Division of Hematology and Cardiology, Graduate School of Medical and Dental Science, Niigata Univer
-
IWANAGA Masako
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer
-
JINNAI Itsuro
Nagasaki CML Study Group
-
KURIYAMA Kazutaka
Nagasaki CML Study Group
-
OKAMOTO Shinichiro
Division of Hematology, Department of Medicine, Keio University School of Medicine
-
OHYASHIKI Kazuma
First Department of Internal Medicine (Division of Hematology), Tokyo Medical University
-
HASHIGUCHI Michitoshi
Division of Hematology, Department of Medicine, Kurume University School of Medicine
-
Ando Kiyoshi
Division of Hematology and Oncology, Tokai University School of Medicine
-
KANDA Yoshinobu
Department of Hematology and Oncology, Graduate School of Medicine, University of Tokyo
-
Seino Yoshihiko
Department Of Internal Medicine Cardiovascular Center Nippon Medical School Chiba-hokusoh Hospital
-
Hashiguchi Michitoshi
久留米大学 医学部血液内科
-
Seki Ritsuko
Second Department Of Internal Medicine Kurume University School Of Medicine
-
OHTSU Tomoko
Amgen Limited
-
OHTSU Tomoko
Division of Oncology/Hematology, Department of Medicine, National Cancer Center Hospital East
-
NAGAFUJI Koji
Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences
-
FUJITA Hiroyuki
Department of Rheumatology/Hematology/Infectious Disease, Yokohama City University Hospital
-
Nagafuji K
Medicine And Biosystemic Science Kyushu University Graduate School Of Medical Sciences
-
Nagafuji Koji
九州大学 医学研究院病態修復内科学
-
Nagafuji Koji
高木病院
-
Nagafuji Koji
Department Of Hematology Hara Sanshin General Hospital
-
Tsuchiya S
Department Of Pediatrics Tohoku University School Of Medicine
-
Muta K
Department Of Pathology School Of Medicine Fukuoka University
-
ISHIDA Yoji
Division of Hematology/Oncology, Iwate Medical University School of Medicine
-
Hatsumi Naoko
Japan Adult Leukemia Study Group Hamamatsu Jpn
-
Sumiyoshi Yoshiaki
Department Of Pathology School Of Medicine Kurume University
著作論文
- Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia : the JALSG AML95 study
- Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in Japan : a retrospective analysis of 1,057 cases from Kyushu Lymphoma Study Group
- Comparative analysis of remission induction therapy for high-risk MDS and AML progressed from MDS in the MDS200 study of Japan Adult Leukemia Study Group
- Molecular monitoring of BAALC expression in patients with CD34-positive acute leukemia
- Linkage of expression of chemokine receptors (CXCR3 and CCR4) and cytotoxic molecules in peripheral T cell lymphoma, not otherwise specified and ALK-negative anaplastic large cell lymphoma
- Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan
- Management of infection in patients with acute leukemia during chemotherapy in Japan : questionnaire analysis by the Japan Adult Leukemia Study Group
- Mantle cell lymphoma shows three morphological evolutions of classical, intermediate, and aggressive forms, which occur in parallel with increased labeling index of cyclin D1 and Ki-67
- Imatinib for newly diagnosed chronic-phase chronic myeloid leukemia : results of a prospective study in Japan
- Mikulicz's disease with severe thrombocytopenia following autologous stem cell transplantation in a multiple myeloma patient
- Safe switching from dasatinib to nilotinib after a 1-month off-drug period for persistent pleural effusion in patients with chronic myelogenous leukemia in chronic phase
- A high risk of life-threatening infectious complications in mycophenolate mofetil treatment for acute or chronic graft-versus-host disease
- Clinical features of dasatinib-induced large granular lymphocytosis and pleural effusion
- Cystatin C level as a marker of renal function in allogeneic hematopoietic stem cell transplantation
- Prognostic impact of immunohistochemical biomarkers in diffuse large B-cell lymphoma in the rituximab era
- Erythrocytosis caused by erythropoietin-producing thymic carcinoma
- Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia : the JALSG-ALL97 study
- Phase II study of ABVd therapy for newly diagnosed clinical stage II-IV Hodgkin lymphoma : Japan Clinical Oncology Group study (JCOG 9305)
- Trough plasma concentration of imatinib reflects BCR-ABL kinase inhibitory activity and clinical response in chronic-phase chronic myeloid leukemia : A report from the BINGO study
- Clinical efficacy and safety of biapenem for febrile neutropenia in patients with underlying hematopoietic diseases : a multi-institutional study